LIVE
Login☆ WatchlistAPI Docs
Markets
NSE StocksBSE StocksF&ORates & G-SecsCurrenciesSectorsCommodities
News
Corporate AnnouncementsGovernment & PolicyFixed IncomeETFsFXAlt. InvestingEconomic Calendar
Sections
EconomicsTechFinancePoliticsWealth
Language
Englishहिन्दीગુજરાતીमराठी

MARKSANS

NSEBSE
Marksans Pharma Limited
Healthcare· Pharmaceuticals & Biotechnology· INE750C01026· Scrip: 524404
ENहिन्दीગુજરાતીमराठी
૧૯૬.૬૬
9.74 (+5.21%)
6/5/2026, 3:28:22 pm
NSE
૧૯૬.૬૬
૯.૭૪
+૫.૨૧%
BSE
૧૯૬.૩૫
૮.૮૦
+૦.૦૦%
16018621323926505-0707-0208-2910-2812-2402-2304-3005-06
૨૪૪ ટ્રેડિંગ દિવસ · 1Y સમયગાળો
આજ
ખૂલ્લ૧૮૮.૯૦
ઊંચ૨૦૭.૦૦
નીચ૧૮૮.૩૦
અગાઉ બંધ૧૮૬.૯૨
વૉલ્યુમ૮૭.૯૧L
મૂલ્ય₹૧૭૫.૭Cr
L: 188.30H: 207.00
52 સપ્તાહ
નીચ૧૫૫.૦૦
ઊંચ૨૭૦.૭૦
૩૬% 52 સપ્તાહ રેન્જમાં
માહિતી
અંકિત મૂલ્ય₹૧
સૂચિબદ્ધ2002-01-21
ISININE750C01026
SeriesA
BSE સ્ક્રિપ524404

મુખ્ય સૂચકો

1D
+5.21%
1W
+6.82%
1M
+17.03%
3M
+20.45%
6M
+10.17%
મૂલ્યાંકન
P/E (TTM)૨૮.૫૮
P/E (Qtr Ann.)૨૧.૨૮
P/Sales૩.૫૬
વૃદ્ધિ (ત્રિ.)
આવક+6.22%
PAT+7.47%
EPS+8.45%
નફાકારકતા
TTM EBITDA M.૨૨.૪%
TTM આવક
₹2138 Cr
TTM EBITDA
₹479 Cr
TTM PAT
₹312 Cr
TTM EPS
₹૬.૮૮

ત્રિમાસિક નાણાકીય

આવક
EBITDA
PAT
EPS
0 Cr170 Cr341 Cr511 Cr682 Cr22-1223-0323-0923-1224-0324-0624-0924-121.62.01.81.81.70.72.12.3
ત્રિમાસઆવકExpensesEBITDAPBTPATEPS
2024-12-31682 Cr566 Cr164 Cr143 Cr105 Cr2.31
2024-09-30642 Cr528 Cr144 Cr125 Cr98 Cr2.13
2024-06-30255 Cr220 Cr49 Cr42 Cr32 Cr0.71
2024-03-31560 Cr476 Cr121 Cr100 Cr78 Cr1.73
2023-12-31586 Cr478 Cr135 Cr113 Cr83 Cr1.84
2023-09-30531 Cr436 Cr131 Cr114 Cr84 Cr1.84
2023-03-31486 Cr393 Cr118 Cr104 Cr83 Cr1.97
2022-12-31480 Cr418 Cr92 Cr79 Cr62 Cr1.56

શેરહોલ્ડિંગ પેટર્ન

વર્તમાન2026-03-31
43.9%પ્રમોટર
પ્રમોટર43.9%
FII16.8%
DII6.6%
સાર્વજનિક56.1%
પ્રમોટર હોલ્ડિંગ ટ્રેન્ડ
43.9%24-0643.9%24-0943.9%24-1243.9%25-0343.9%25-0943.9%25-1243.9%26-03

કોર્પોરેટ ક્રિયાઓ

એક્સ-તારીખપ્રકારહેતુ
2025-08-01DividendDividend - Re 0.80 Per Share
2024-09-17DividendDividend - Rs 0.60 Per Share
2023-06-07DividendDividend - Re 0.50 Per Share
2022-08-19DividendAnnual General Meeting/Dividend - Rs 0.25 Per Share
2021-09-15Dividend Annual General Meeting/Dividend - Rs 0.25 Per Share
2021-07-01Other Extra-Ordinary General Meeting
2020-09-22Dividend Annual General Meeting/Dividend - Rs 0.10 Per Share
2019-09-19Dividend Annual General Meeting/Dividend - Rs 0.05 Per Share
2018-09-19Dividend Annual General Meeting/Dividend Re 0.05 Per Share
2017-09-19Dividend Annual General Meeting/Dividend - Re 0.05 Per Share
2016-09-22Dividend Annual General Meeting/Dividend - Re 0.12 Per Share
2015-09-23Dividend Annual General Meeting/ Dividend - Re 0.12/- Per Share
2014-09-18DividendAnnual General Meeting / Dividend - Re 0.10/- Per Share
2013-09-19OtherAnnual General Meeting
2012-09-20OtherAnnual General Meeting
2011-09-22OtherAnnual General Meeting
2010-09-22OtherAnnual General Meeting
2009-09-17OtherAnnual General Meeting
2008-09-23OtherAnnual General Meeting
2008-03-11SplitFv Split Rs.10/- To Re.1/

કમાણી ટ્રાન્સક્રિપ્ટ

Marksans Pharma Limited has informed the Exchange about Investor Presentation
13 Nov 2025NSE40K chars
Read →
Marksans Pharma Limited has informed the Exchange about Schedule of a conference call for analysts ...
31 Oct 2025NSE2K chars
Read →
Marksans Pharma Limited has informed the Exchange about Investor Presentation
12 Aug 2025NSE37K chars
Read →
Marksans Pharma Limited has informed the Exchange about Investor Presentation
19 May 2025NSE37K chars
Read →
Marksans Pharma Limited has informed the Exchange about Investor Presentation
11 Feb 2025NSE35K chars
Read →
Marksans Pharma Limited has informed the Exchange about Investor Presentation
9 Nov 2023NSE25K chars
Read →
Marksans Pharma Limited has informed the Exchange about Link of Recording of Q1 Financial Results Co...
17 Aug 2023NSE1K chars
Read →
Marksans Pharma Limited has informed the Exchange about Investor Presentation
30 May 2023NSE51K chars
Read →
Marksans Pharma Limited has informed the Exchange about Investor Presentation
13 Feb 2023NSE50K chars
Read →
Marksans Pharma Limited has informed the Exchange that Earnings Conference Call has been preponed to...
7 Feb 2023NSE2K chars
Read →
Marksans Pharma Limited has informed the Exchange about Transcript of Analysts/Institutional Investo...
21 Nov 2022NSE44K chars
Read →
Marksans Pharma Limited has informed the Exchange about Investor Presentation
14 Nov 2022NSE50K chars
Read →
Marksans Pharma Limited has informed the Exchange about Transcript of Analysts/Institutional Investo...
19 Aug 2022NSE46K chars
Read →
Marksans Pharma Limited has informed the Exchange about Investor Presentation
13 Aug 2022NSE46K chars
Read →
Marksans Pharma Limited has informed the Exchange about Schedule of Q1FY23 Earnings Call.
9 Aug 2022NSE2K chars
Read →
Marksans Pharma Limited has informed the Exchange about Transcript of Analysts/Institutional Investo...
6 Jun 2022NSE34K chars
Read →
Marksans Pharma Limited has informed the Exchange about Investor Presentation
30 May 2022NSE35K chars
Read →
Marksans Pharma Limited has informed the Exchange about Schedule of Q4&FY22 Results Conference Call.
24 May 2022NSE2K chars
Read →
Marksans Pharma Limited has informed the Exchange about Investor Presentation
11 Feb 2022NSE33K chars
Read →
Marksans Pharma Limited has informed the Exchange about Schedule of Conference Call with Seven Canyo...
17 Dec 2021NSE1K chars
Read →

ભાવ ઇતિહાસ

તારીખખૂલ્લઊંચનીચબંધવૉલ્યુમ
2026-05-06૧૮૮.૯૦૨૦૭.૦૦૧૮૮.૩૦૧૯૬.૨૦૮૮.૩૨L
2026-05-05૧૯૦.૦૦૧૯૦.૬૦૧૮૫.૦૦૧૮૬.૯૨૬.૪૦L
2026-05-04૧૮૭.૫૫૧૯૩.૩૩૧૮૬.૩૫૧૮૯.૨૯૧૦.૬૯L
2026-04-30૧૮૭.૦૦૧૮૭.૮૮૧૮૧.૦૦૧૮૪.૬૩૬.૧૦L
2026-04-29૧૮૫.૭૦૧૯૧.૧૦૧૮૫.૦૦૧૮૭.૭૬૮.૩૮L
2026-04-28૧૯૧.૯૯૧૯૩.૦૬૧૮૩.૧૧૧૮૪.૧૦૧૦.૯૮L
2026-04-27૧૯૧.૦૦૧૯૫.૦૦૧૯૦.૨૪૧૯૨.૧૨૮.૧૫L
2026-04-24૧૯૫.૦૦૧૯૫.૦૦૧૮૭.૦૦૧૯૦.૨૧૧૪.૭૯L
2026-04-23૧૭૮.૦૦૧૯૫.૬૮૧૭૭.૬૭૧૯૩.૨૫૪૩.૭૯L
2026-04-22૧૭૬.૨૦૧૮૦.૧૧૧૭૫.૮૫૧૭૯.૫૬૫.૭૫L
2026-04-21૧૭૭.૦૯૧૭૮.૯૦૧૭૫.૫૩૧૭૬.૭૭૬.૮૮L
2026-04-20૧૭૯.૨૩૧૭૯.૨૩૧૭૫.૨૧૧૭૬.૯૦૫.૫૦L
2026-04-17૧૮૧.૯૦૧૮૧.૯૦૧૭૮.૩૦૧૭૯.૨૩૬.૦૬L
2026-04-16૧૮૦.૦૦૧૮૧.૯૯૧૭૬.૯૫૧૮૦.૧૮૪.૮૩L
2026-04-15૧૭૭.૦૦૧૮૦.૭૨૧૭૬.૦૫૧૭૮.૯૨૬.૧૦L
2026-04-13૧૭૩.૦૦૧૭૮.૨૫૧૭૧.૫૦૧૭૬.૧૪૪.૯૬L
2026-04-10૧૭૭.૨૦૧૮૦.૫૦૧૭૫.૪૫૧૭૮.૪૮૪.૯૯L
2026-04-09૧૭૬.૦૦૧૭૮.૫૦૧૭૩.૩૯૧૭૪.૯૮૫.૫૦L
2026-04-08૧૭૬.૦૦૧૭૬.૦૦૧૭૨.૦૦૧૭૪.૬૦૬.૪૬L
2026-04-07૧૬૬.૮૦૧૭૧.૩૦૧૬૨.૯૧૧૭૦.૦૦૮.૪૧L
2026-04-02૧૬૩.૬૬૧૬૯.૧૭૧૬૦.૬૦૧૬૮.૧૫૫.૫૧L
2026-04-01૧૬૫.૦૦૧૭૧.૪૮૧૬૦.૮૨૧૬૮.૦૪૯.૧૮L
2026-03-27૧૬૪.૦૫૧૬૫.૫૦૧૬૦.૫૦૧૬૩.૦૮૧૦.૮૬L
2026-03-25૧૬૫.૩૫૧૬૮.૩૦૧૬૩.૬૦૧૬૫.૨૦૮.૧૪L
2026-03-24૧૬૩.૦૦૧૬૭.૯૯૧૫૯.૭૦૧૬૪.૫૪૧૩.૦૬L
2026-03-20૧૬૨.૩૩૧૭૧.૮૦૧૬૨.૨૫૧૭૦.૦૫૧૧.૪૫L
2026-03-19૧૬૭.૦૦૧૬૭.૩૦૧૬૧.૦૧૧૬૧.૪૧૪.૨૫L
2026-03-18૧૬૪.૯૦૧૬૯.૭૫૧૬૪.૫૯૧૬૭.૮૯૬.૪૧L
2026-03-17૧૬૪.૭૬૧૬૬.૦૦૧૬૩.૫૦૧૬૩.૯૭૪.૬૧L
2026-03-16૧૬૭.૮૪૧૬૮.૨૪૧૬૨.૬૮૧૬૪.૭૬૫.૯૦L

વારંવાર પૂછાતા પ્રશ્નો

વિશે

Marksans Pharma Limited એ વૈશ્વિક હાજરી ધરાવતી ભારતીય ફાર્માસ્યુટિકલ કંપની છે, જે ફિનિશ્ડ ડોઝ ફોર્મ્સના સંશોધન, ઉત્પાદન અને માર્કેટિંગમાં વિશેષતા ધરાવે છે. મુખ્ય ઉત્પાદનોમાં કાર્ડિયોવેસ્ક્યુલર, સેન્ટ્રલ નર્વસ સિસ્ટમ અને મેટાબોલિક ડિસઓર્ડર માટે ફોર્મ્યુલેશનનો સમાવેશ થાય છે.

Advertisement
BOARD OF DIRECTORS
Mark Saldanha
Managing Director
Vinay Gopal Nayak
Whole-time Director
DEPARTED
Abhinna Sundar Mohanty
Independent Director
Digant Mahesh Parikh
Independent Director
Meena Rani Surana
Independent Director
Seetharama Raju Buddharaju
Independent Director
DEPARTED
DEPARTED